Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study

Yan-Jun Xiang, Zong-Han Liu, Jin-Kai Feng, Ying-Yi Qin, Hong-Ming Yu, Yu-Qiang Cheng, Gang Chen, Jia-Yi Wu, Yong-Yi Zeng, Yu-Fu Tang, Jian-Hua Rao, Feng-Min Zhang, Shi-Ye Yang, Gui-Ran Wang, Lin-Sen Ye, Ren Lang, Jian-Hua Lin, Yi-Tao Zheng, Ye-Fan Mao, Hong-Kun Zhou, Mao-Lin Yan, Chao Liang, Si-Si Ren, Kang Wang, Lin Gong, Shuai Xu, Yun-Fei Xu, Qing-Qiang Ni, Kai Wang, Rui-Fang Fan, Yi-Lin Hu, Tao Jiang, Chao Lin, Qing-Lun Gao, Zhi-Qiang Wang, Yi-Meng Lu, Wen-Bo Zou, Xiao Wang, Chen Feng, Zi-Cheng Wang, Peng-Jiong Liu, Wen-Jing Wei, Fan Zhang, Wei Wu, Hao-Feng Lu, Jing-Yi Huang, Xin Liang, Jing-Jing Li, Yun-Feng Shan, Xiu-Ping Zhang, Shu-Qun Cheng

Open source

DOI: 10.1136/gutjnl-2026-338462
Published: 2026-07-03
Container: Gut
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/gutjnl-2026-338462,
  title = {Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study},
  author = {Yan-Jun Xiang and Zong-Han Liu and Jin-Kai Feng and Ying-Yi Qin and Hong-Ming Yu and Yu-Qiang Cheng and Gang Chen and Jia-Yi Wu and Yong-Yi Zeng and Yu-Fu Tang and Jian-Hua Rao and Feng-Min Zhang and Shi-Ye Yang and Gui-Ran Wang and Lin-Sen Ye and Ren Lang and Jian-Hua Lin and Yi-Tao Zheng and Ye-Fan Mao and Hong-Kun Zhou and Mao-Lin Yan and Chao Liang and Si-Si Ren and Kang Wang and Lin Gong and Shuai Xu and Yun-Fei Xu and Qing-Qiang Ni and Kai Wang and Rui-Fang Fan and Yi-Lin Hu and Tao Jiang and Chao Lin and Qing-Lun Gao and Zhi-Qiang Wang and Yi-Meng Lu and Wen-Bo Zou and Xiao Wang and Chen Feng and Zi-Cheng Wang and Peng-Jiong Liu and Wen-Jing Wei and Fan Zhang and Wei Wu and Hao-Feng Lu and Jing-Yi Huang and Xin Liang and Jing-Jing Li and Yun-Feng Shan and Xiu-Ping Zhang and Shu-Qun Cheng},
  year = {2026},
  journal = {Gut},
  doi = {10.1136/gutjnl-2026-338462},
  url = {https://doi.org/10.1136/gutjnl-2026-338462}
}

RIS

TY  - JOUR
TI  - Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study
AU  - Yan-Jun Xiang
AU  - Zong-Han Liu
AU  - Jin-Kai Feng
AU  - Ying-Yi Qin
AU  - Hong-Ming Yu
AU  - Yu-Qiang Cheng
AU  - Gang Chen
AU  - Jia-Yi Wu
AU  - Yong-Yi Zeng
AU  - Yu-Fu Tang
AU  - Jian-Hua Rao
AU  - Feng-Min Zhang
AU  - Shi-Ye Yang
AU  - Gui-Ran Wang
AU  - Lin-Sen Ye
AU  - Ren Lang
AU  - Jian-Hua Lin
AU  - Yi-Tao Zheng
AU  - Ye-Fan Mao
AU  - Hong-Kun Zhou
AU  - Mao-Lin Yan
AU  - Chao Liang
AU  - Si-Si Ren
AU  - Kang Wang
AU  - Lin Gong
AU  - Shuai Xu
AU  - Yun-Fei Xu
AU  - Qing-Qiang Ni
AU  - Kai Wang
AU  - Rui-Fang Fan
AU  - Yi-Lin Hu
AU  - Tao Jiang
AU  - Chao Lin
AU  - Qing-Lun Gao
AU  - Zhi-Qiang Wang
AU  - Yi-Meng Lu
AU  - Wen-Bo Zou
AU  - Xiao Wang
AU  - Chen Feng
AU  - Zi-Cheng Wang
AU  - Peng-Jiong Liu
AU  - Wen-Jing Wei
AU  - Fan Zhang
AU  - Wei Wu
AU  - Hao-Feng Lu
AU  - Jing-Yi Huang
AU  - Xin Liang
AU  - Jing-Jing Li
AU  - Yun-Feng Shan
AU  - Xiu-Ping Zhang
AU  - Shu-Qun Cheng
PY  - 2026
JO  - Gut
DO  - 10.1136/gutjnl-2026-338462
UR  - https://doi.org/10.1136/gutjnl-2026-338462
ER  -

APA

Xiang, Y., Liu, Z., Feng, J., Qin, Y., Yu, H., Cheng, Y., Chen, G., Wu, J., Zeng, Y., Tang, Y., Rao, J., Zhang, F., Yang, S., Wang, G., Ye, L., Lang, R., Lin, J., Zheng, Y., Mao, Y., Zhou, H., Yan, M., Liang, C., Ren, S., Wang, K., Gong, L., Xu, S., Xu, Y., Ni, Q., Wang, K., Fan, R., Hu, Y., Jiang, T., Lin, C., Gao, Q., Wang, Z., Lu, Y., Zou, W., Wang, X., Feng, C., Wang, Z., Liu, P., Wei, W., Zhang, F., Wu, W., Lu, H., Huang, J., Liang, X., Li, J., Shan, Y., Zhang, X., & Cheng, S. (2026). Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study. Gut. https://doi.org/10.1136/gutjnl-2026-338462

Source records

crossref · retrieved 2026-09-27T14:36:13.757Z